These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33239887)

  • 61. Thrombospondin-1 is a prognostic biomarker and is correlated with tumor immune microenvironment in glioblastoma.
    Qi C; Lei L; Hu J; Wang G; Liu J; Ou S
    Oncol Lett; 2021 Jan; 21(1):22. PubMed ID: 33240428
    [TBL] [Abstract][Full Text] [Related]  

  • 62. STAT6 expression in glioblastoma promotes invasive growth.
    Merk BC; Owens JL; Lopes MB; Silva CM; Hussaini IM
    BMC Cancer; 2011 May; 11():184. PubMed ID: 21595984
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Adult diffuse glioma GWAS by molecular subtype identifies variants in D2HGDH and FAM20C.
    Eckel-Passow JE; Drucker KL; Kollmeyer TM; Kosel ML; Decker PA; Molinaro AM; Rice T; Praska CE; Clark L; Caron A; Abyzov A; Batzler A; Song JS; Pekmezci M; Hansen HM; McCoy LS; Bracci PM; Wiemels J; Wiencke JK; Francis S; Burns TC; Giannini C; Lachance DH; Wrensch M; Jenkins RB
    Neuro Oncol; 2020 Nov; 22(11):1602-1613. PubMed ID: 32386320
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Integrative analysis of KIF4A, 9, 18A, and 23 and their clinical significance in low-grade glioma and glioblastoma.
    Cho SY; Kim S; Kim G; Singh P; Kim DW
    Sci Rep; 2019 Mar; 9(1):4599. PubMed ID: 30872592
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The phosphorylation of ephrin-B2 ligand promotes glioma cell migration and invasion.
    Nakada M; Anderson EM; Demuth T; Nakada S; Reavie LB; Drake KL; Hoelzinger DB; Berens ME
    Int J Cancer; 2010 Mar; 126(5):1155-65. PubMed ID: 19728339
    [TBL] [Abstract][Full Text] [Related]  

  • 66. High expression of GALNT7 promotes invasion and proliferation of glioma cells.
    Hua S; Li H; Liu Y; Zhang J; Cheng Y; Dai C
    Oncol Lett; 2018 Nov; 16(5):6307-6314. PubMed ID: 30405766
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Identification of Iron Metabolism-Related Genes as Prognostic Indicators for Lower-Grade Glioma.
    Xu S; Wang Z; Ye J; Mei S; Zhang J
    Front Oncol; 2021; 11():729103. PubMed ID: 34568059
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Reprogramming the immunosuppressive microenvironment of IDH1 wild-type glioblastoma by blocking Wnt signaling between microglia and cancer cells.
    Fan D; Yue Q; Chen J; Wang C; Yu R; Jin Z; Yin S; Wang Q; Chen L; Liao X; Peng C; Zhang J; Cao Z; Mao Y; Huang R; Chen L; Li C
    Oncoimmunology; 2021 Jun; 10(1):1932061. PubMed ID: 34123575
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immune Infiltration-Related Signature Predicts Risk Stratification and Immunotherapy Efficacy in Grade II and III Gliomas.
    Luo C; Liu Z; Ye W; Liu F
    Front Cell Dev Biol; 2021; 9():756005. PubMed ID: 34805164
    [No Abstract]   [Full Text] [Related]  

  • 70. HOXC6/8/10/13 predict poor prognosis and associate with immune infiltrations in glioblastoma.
    Yu M; Yu S; Zhou W; Yi B; Liu Y
    Int Immunopharmacol; 2021 Dec; 101(Pt A):108293. PubMed ID: 34763232
    [TBL] [Abstract][Full Text] [Related]  

  • 71. ARL3 is downregulated and acts as a prognostic biomarker in glioma.
    Wang Y; Zhao W; Liu X; Guan G; Zhuang M
    J Transl Med; 2019 Jun; 17(1):210. PubMed ID: 31234870
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma.
    Luedi MM; Singh SK; Mosley JC; Hassan ISA; Hatami M; Gumin J; Andereggen L; Sulman EP; Lang FF; Stueber F; Fuller GN; Colen RR; Zinn PO
    J Neurosurg; 2018 Dec; 129(6):1446-1455. PubMed ID: 29328002
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
    Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
    BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Differential gene expression in peritumoral brain zone of glioblastoma: role of SERPINA3 in promoting invasion, stemness and radioresistance of glioma cells and association with poor patient prognosis and recurrence.
    Nimbalkar VP; Kruthika BS; Sravya P; Rao S; Sugur HS; Verma BK; Chickabasaviah YT; Arivazhagan A; Kondaiah P; Santosh V
    J Neurooncol; 2021 Mar; 152(1):55-65. PubMed ID: 33389566
    [TBL] [Abstract][Full Text] [Related]  

  • 75. PLEKHG5 is a novel prognostic biomarker in glioma patients.
    Qian M; Chen Z; Wang S; Guo X; Zhang Z; Qiu W; Gao X; Xu J; Zhao R; Xue H; Li G
    Int J Clin Oncol; 2019 Nov; 24(11):1350-1358. PubMed ID: 31309383
    [TBL] [Abstract][Full Text] [Related]  

  • 76. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
    J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Quiescent stem cell marker genes in glioma gene networks are sufficient to distinguish between normal and glioblastoma (GBM) samples.
    Mukherjee S
    Sci Rep; 2020 Jul; 10(1):10937. PubMed ID: 32616845
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Differentiated glioblastoma cells accelerate tumor progression by shaping the tumor microenvironment via CCN1-mediated macrophage infiltration.
    Uneda A; Kurozumi K; Fujimura A; Fujii K; Ishida J; Shimazu Y; Otani Y; Tomita Y; Hattori Y; Matsumoto Y; Tsuboi N; Makino K; Hirano S; Kamiya A; Date I
    Acta Neuropathol Commun; 2021 Feb; 9(1):29. PubMed ID: 33618763
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identification of a Metabolism-Related Risk Signature Associated With Clinical Prognosis in Glioblastoma Using Integrated Bioinformatic Analysis.
    He Z; Wang C; Xue H; Zhao R; Li G
    Front Oncol; 2020; 10():1631. PubMed ID: 33042807
    [TBL] [Abstract][Full Text] [Related]  

  • 80. DNA copy number analysis of Grade II-III and Grade IV gliomas reveals differences in molecular ontogeny including chromothripsis associated with IDH mutation status.
    Cohen A; Sato M; Aldape K; Mason CC; Alfaro-Munoz K; Heathcock L; South ST; Abegglen LM; Schiffman JD; Colman H
    Acta Neuropathol Commun; 2015 Jun; 3():34. PubMed ID: 26091668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.